Product Added to Cart!
$147.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI14295_250_MG
Chem Impex
Get Bulk Quote

Product Information

Product Name
Na-Fmoc-Nim-benzyl-D-histidine
Brand Name
Chem Impex
Product Number
14295
CAS
2022956-32-5
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
100110
IUPAC Name
3-(1-benzylimidazol-4-yl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
InChI Key
AZBCBZPTQNYCPF-UHFFFAOYSA-N
SMILES
C1=CC=C(C=C1)CN2C=C(N=C2)CC(C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35

Description

Na-Fmoc-Nim-benzyl-D-histidine is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, particularly in the development of therapeutic agents. Its protective Fmoc group allows for selective deprotection during synthesis, enhancing efficiency.

Drug Development: Researchers use this compound in the design of novel drugs that target specific biological pathways, especially in cancer and metabolic disorders, due to its unique structural properties.

Bioconjugation: The compound can be employed in bioconjugation processes, linking biomolecules to therapeutic agents, which improves drug delivery and efficacy in targeted therapies.

Protein Engineering: It plays a significant role in protein engineering, where it is used to modify proteins for improved stability and function, aiding in the development of biopharmaceuticals.

Diagnostics: Na-Fmoc-Nim-benzyl-D-histidine is also explored in diagnostic applications, particularly in the development of biosensors that detect specific biomolecules, enhancing disease detection capabilities.

References Data Source From Pubchem

Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells

Publication Name: Biochemical and Biophysical Research Communications
Publication Date: 2023-10-30
DOI: 10.1016/j.bbrc.2023.08.050

A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2

Publication Name: The Journal of biological chemistry
Publication Date: 2022-08
DOI: 10.1016/j.jbc.2022.102228